Navigation Links
US Oncology Announces Retirement of General Counsel Phil Watts
Date:11/10/2009

THE WOODLANDS, Texas, Nov. 10 /PRNewswire/ -- Today, US Oncology, Inc. announced that Phillip Watts, executive vice president and general counsel, will be departing from the Company, effective November 30, 2009.

(Photo: http://www.newscom.com/cgi-bin/prnh/20091110/DA08765)

Watts has had a long and rich history with US Oncology. Beginning in 1993, he worked with US Oncology providing legal services and consultation as an outside attorney before joining the Company in 1998 as its General Counsel.

"Phil has been involved in the US Oncology organization for 16 years," said CEO Bruce Broussard. "In that context, he is going to take some time away from business to spend quality time with his family prior to continuing his career. While we will miss Phil's wit, logical analysis and leadership, we wish him the best as he takes some time with his family to reflect on his next stage of life."

During his tenure at US Oncology, Watts has demonstrated his leadership by developing a strong and experienced legal team, which will remain with the company. US Oncology will conduct a search for Watts' replacement, which will include internal candidates.

In addition to his legal responsibilities, Watts oversaw the company's strategic initiatives and public policy activities, which both will be supported by Grant Bogle, executive vice president, Integrated Oncology Solutions Group with US Oncology.

About US Oncology

US Oncology, Inc., headquartered in The Woodlands, Texas, works closely with physicians, payers, biotechnology, pharmaceutical and medical equipment manufacturers, to identify and deliver innovative services that enhance patient access to advanced cancer care. US Oncology supports one of the nation's foremost cancer treatment and research networks, accelerating the availability and use of evidence-based medicine and shared best practices.

US Oncology uses its expertise to support every aspect of the cancer care delivery system--from drug development to distribution and outcomes measurement--enabling the company to help increase the efficiency and safety of cancer care. According to the company's last quarterly earnings report, US Oncology is affiliated with 1,310 physicians operating in 493 locations, including 98 radiation oncology facilities in 39 states. For more information, visit the company's Web site, www.usoncology.com.

SOURCE US Oncology, Inc.


'/>"/>
SOURCE US Oncology, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Six UK Hospitals Join Together in Using Varian Medical Oncology Information Network
2. Genstruct CEO, Dr. Keith Elliston, Invited to Speak at Oncology Clinical Trial Summit
3. Founder of ILEX Oncology and Triton Biosciences, Richard Love, Joins Board of Directors of Cell Therapeutics, Inc. (CTI)
4. Ranbaxy to Consolidate Position in Biopharmaceuticals and Speciality Injectables Including Oncology
5. Pharsight Invited to Present on Oncology Modeling and Simulation at Quantitative Pharmacology Symposium in China
6. PRA International to Present Audioconference on Oncology Research - Nov. 8
7. IMPAC Medical Systems to Offer Revenue Cycle Inc.s Array of Oncology Products and Services to Customers
8. AG Mednet to Provide Image Network for Southwest Oncology Group
9. Quest PharmaTech to Receive $3,000,000 to Develop Oncology Products Based on its SonoLight Technology
10. Center for Molecular Medicine Selected to Provide DNA Analysis for Childrens Oncology Group Leukemia Study
11. Oncology Metrics and Cureline Announce Joint Marketing Agreement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)...  Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage ... for metabolic and endocrine disorders, today announced that its ... deliver a corporate presentation at H.C. Wainwright & Co.,s ... April 3, 2017 at the St. Regis Hotel in ... are as follows: H.C. Wainwright ...
(Date:3/28/2017)... March 28, 2017 Focus ... unpredictable sector due to the scientifically intensive operations ... medical, agricultural, environmental, and industrial. In today,s pre-market research, ... Pharmaceuticals Inc. (NASDAQ: PTLA), OvaScience Inc. (NASDAQ: OVAS), ... Inc. (NASDAQ: OCUL ). Learn more ...
(Date:3/27/2017)... WARREN, N.J. , March 27, 2017 Roka ... providing advanced testing solutions for the detection of foodborne pathogens, ... at the Sidoti & Company Spring 2017 Convention on March ... the New York Marriott Marquis. About Roka ... ...
(Date:3/27/2017)... , March 27, 2017  The global market ... 2016, according to a new report from Kalorama ... testing is performed to evaluate disease progression, monitor ... among other reasons.  The healthcare market research firm,s ... , provides an overview of the medical laboratory ...
Breaking Biology Technology:
(Date:3/2/2017)... 2, 2017 Summary This report ... Merck KGaA and its partnering interests and activities since ... Description The Partnering Deals and Alliance since 2010 ... of one of the world,s leading life sciences companies. ... purchase to ensure inclusion of the most up to ...
(Date:2/28/2017)... 2017 News solutions for biometrics, bag drop ... ... 14 to 16 March, Materna will present its complete end-to-end ... travel is a real benefit for passengers. To accelerate the ... passenger touch point solutions to take passengers through the complete ...
(Date:2/22/2017)... LONDON , Feb. 22, 2017 ... by 2021, ABI Research identifies four technologies that ... solutions to secure significant share in the changing ... payments, and passive authentication.   "Companies ... it comes to security," says Dimitrios Pavlakis ...
Breaking Biology News(10 mins):